Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,097 | -8,040 | -3,883 | -12,518 | -8,947 |
| Depreciation Amortization | 3,383 | 1,840 | 796 | 2,530 | 2,067 |
| Accounts receivable | -9 | -2 | N/A | 9 | 12 |
| Accounts payable and accrued liabilities | -379 | -457 | -290 | -516 | -343 |
| Other Working Capital | 208 | 135 | -87 | -46 | 245 |
| Other Operating Activity | 4,786 | 3,128 | 1,484 | 5,436 | 3,414 |
| Operating Cash Flow | $-5,108 | $-3,397 | $-1,980 | $-5,105 | $-3,552 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -29 | N/A | -13 | -13 |
| Investing Cash Flow | $-36 | $-29 | $N/A | $-13 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,333 | 5,991 | 3,074 | 5,058 | 3,062 |
| Debt Repayment | -4,350 | -2,542 | -1,315 | -863 | -433 |
| Common Stock Issued | 1,156 | 1,156 | 600 | 589 | 589 |
| Other Financing Activity | -14 | -13 | 0 | 0 | 0 |
| Financing Cash Flow | $5,124 | $4,593 | $2,359 | $4,783 | $3,218 |
| Beginning Cash Position | 118 | 118 | 118 | 452 | 452 |
| End Cash Position | 98 | 1,284 | 496 | 118 | 105 |
| Net Cash Flow | $-19 | $1,166 | $379 | $-334 | $-346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,108 | -3,397 | -1,980 | -5,105 | -3,552 |
| Capital Expenditure | -36 | -29 | N/A | -13 | -13 |
| Free Cash Flow | -5,143 | -3,427 | -1,980 | -5,118 | -3,564 |